Broker Notes, Comments and Analysis

Broker notes, analysis and comments

OnTheMarket Converting agents to paying contracts

What’s new:  OnTheMarket has announced that “as at 2 December 2019, over 3,000 more offices had been signed under new paying contracts to list all their residential properties at OnTheMarket . The progress builds on the support from thousands of..

Advanced Oncotherapy Proving the accuracy and superiority of minibeams

The goal of Advanced Oncotherapy (LON:AVO) is to deliver an affordable and more effective proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. In..

Boohoo “continues to outperform the wider retail market” says Zeus Capital

Boohoo Group has released a brief statement confirming ongoing strong trading across its key brands (boohoo.com, PrettyLittleThing, Nasty Gal and BoohooMAN) and another record-breaking performance over the all-important Black Friday..

Palace Capital 1H’20 results announced

Palace Capital (LON:PCA) 1H’20 results were announced on 19 November. Seventeen lease events have been completed. Impressively, these were 25% above passing rent and 3% above ERV (i.e. previous estimated..

Artificial Solutions Conversational AI leader; customer wins continue

Artificial Solutions (ASAI) is a market leader in the conversational artificial intelligence (AI) segment. Its customers include some of the world’s largest enterprises across market sectors, while partners include many..

Pantheon International Plc History of value added to portfolio by holding Pantheon

In our 6 September initiation report on Pantheon International (11.9% average annual NAV growth since 1987, PIP, ticker PIN), we noted i) PE funds earn better returns than quoted companies,..

Diurnal Group Successful DITEST Phase I trial outcome

Diurnal (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead products, Alkindi and Chronocort, are in late-stage clinical trials, with Alkindi already..

Genedrive Regulatory hurdle leaped: hearing loss assay

Genedrive (LON:GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use device with..

Incanthera Ltd Realising near-term value in oncology

Incanthera is a spin-out from the Institute of Cancer Therapeutics at the University of Bradford to exploit development opportunities generated from this prestigious organisation. This has provided the company with..

Cambria Automobiles “ahead of our forecasts” says Zeus Capital

Cambria Automobiles has delivered another strong set of FY results, which were ahead of our forecasts despite numerous upgrades during the course of the year. We upgrade our 2020E and..

Chamberlin Management actions yield cautious optimism

Trading remains difficult, and cost reduction measures continue to be implemented. Chamberlin is still on track strategically, and the group continues to develop its product offering most favourably. The group..

CentralNic “Team Internet client base represents an upsell opportunity” says Zeus Capital

CentralNic Group (LON:CNIC) has announced the acquisition of Team Internet for a total consideration of $48m. The acquisition will be financed in part by a further €40m bond issue under..

Non-Standard Finance Trading update: understand the accounting

Non-Standard Finance (LON:NSF) has issued a trading update highlighting a 4%-5% reduction in consensus estimates due to softer trading in 3Q (primarily lower loan volumes in guarantor loans, a market..

“An interesting time to invest in Northgate” says Zeus Capital

We believe now is an interesting time to invest in Northgate, with a new executive board and a capable management team in place who have already delivered progress on an..

Neodecortech Robustly positioned for 2019/20

Neodecortech (NDT) has performed well in 2019, in our view, against a difficult economic backdrop. 1H, 3Q and October revenue rose 2%, 6% and 9%, respectively. We are forecasting the..

Advanced Oncotherapy FLASH benefits from new US reimbursement

Advanced Oncotherapy‘s (LON:ONC) goal is to deliver an affordable and novel proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. In the past 18..

Inchcape “well placed to hit 2019E” says Zeus Capital

Revising 2020E and 2021E We update our forecasts following Inchcape’s Q3 IMS on 7th November, and focus our attention on 2020E and 2021E estimates after the Group confirmed it was well..

Lookers Finding the floor

We update our forecasts following Lookers announcement on the 1st November that trading has continued to deteriorate and the now expects adj. PBT in 2019E of £16m (vs ZC forecast of..

Nexus Investments’ Scale-Up Fund

Why Invest Positives Strategy: To fund fast-growth companies in data, digital, education and healthcare, which have existing products, and support them in scaling up. Issues Track record: No exits to date from..

Filta Group FY19 trading update

Filta Group (FLTA) provides cleaning services to commercial kitchens in North America, the UK and, mainland Europe. The company reported that EBITDA for 2H19 would be similar to 1H19 and..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds